Regeneron Pharmaceuticals (REGN) Long-Term Debt Issuances (2009 - 2011)
Regeneron Pharmaceuticals (REGN) posted quarterly Long-Term Debt Issuances of $391.1 million for Q4 2011, up 722.62% quarter-over-quarter from $47.5 million in Q1 2010.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Long-Term Debt Issuances (2009 - 2011) Analysis & Trends
Regeneron Pharmaceuticals' Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $391.1 million for Q4 2011.
- In Q4 2011, Long-Term Debt Issuances changed N/A year-over-year to $391.1 million; the TTM figure through Dec 2021 stood at $391.1 million (changed 0.0% YoY), while the FY2020 annual figure was $2.0 billion, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2011 stood at $391.1 million, up from $47.5 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $391.1 million in Q4 2011, with the low at $18.5 million in Q4 2009.
- The 3-year median for Long-Term Debt Issuances is $47.5 million (2010), against an average of $152.4 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 391.11 Mn |
| Mar 31, 2010 | 47.54 Mn |
| Dec 31, 2009 | 18.46 Mn |